Plasma activity and insertion/deletion polymorphism of angiotensin I- converting enzyme: A major risk factor and a marker of risk for coronary stent restenosis

Circulation

Volumn 97, Issue 2, 1998, Pages 147-154

  Ribichini, Flavio ^a   Steffenino, Giuseppe ^a   Dellavalle, Antonio ^a   Matullo, Giuseppe ^b   Colajanni, Elena ^b   Camilla, Terenzio ^a   Vado, Antonello ^a   Benetton, Gabriella ^b   Uslenghi, Eugenio ^a   Piazza, Alberto ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b NONE

Author keywords

Angiotensin; Coronary disease; Follow up studies; Genes; Stents

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENE DELETION; GENE INSERTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031941151     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.2.147     Document Type: Article

References (40)

1. The Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-95.
2. The Stent Restenosis Study Group (STRESS). A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
3. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
4. Mintz GS, Popma JJ, Pichard A, Kent KM, Satler LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
5. Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB. Intravascuur ultrasound to discern device-specific effects and mechanism of restenosis. Am J Cardiol. 1996;78(suppl 3A):18-22.
6. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanism of in-stent restenosis. a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
7. Painter JA, Mintz GS, Wong SC, Popma JP, Pichard AD, Kent KM, Satler LF, Leon MB. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol. 1995;75:398-400.
8. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
9. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
10. Gardemann A, Weiß T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosh W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation. 1995;92:2796-2799.
11. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med. 1985;312:932-936.
12. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphological and clinical determinations of procedural outcome with multivessel coronary artery disease: implications for patient selection. Circulation. 1990;82:1193-1202.
13. Haase J, Nugteren SK, van Swijndregt EM, Slager CJ, Di Mario C, de Feyter PJ, Serruys PW. Digital geometric measurements in comparison to cinefilms analysis of coronary artery dimensions. Cathet Cardiovasc Diagn. 1993;28:283-290.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1 dipeptidyl carboxypeptidase). Nucl Acids Res. 1992;20:1433.
15. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet. 1994;343:851. Letter.
16. Lindpaintner K. Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
17. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
18. Ohishi M, Fuji K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T. A potent genetic risk factor for restenosis. Nat Genet. 1993;5:324-325.
19. Hamon M, Bauten C, Amant C, McFadden EP, Helbecque N, Lablanche JM, Bertrand ME, Amouyel P. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and the late luminal narrowing after coronary angioplasty. Circulation. 1995;92:296-299.
20. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, Harley A, Swales JD, deBono DP, Gershlick AH. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet. 1995;345:1013-1016.
21. Kaski JC, Zhang Y, Calvino R, Vazquez-Rodriguez JM, Castro-Beiras A, Jeffery S, Carter N. Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol. 1996;77:875-877.
22. van Bockxmeer FM, Mamotte CDS, Gibbons FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92:2066-2071.
23. Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand M. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary scenting. Circulation. 1997;96:56-60.
24. Rakugi H, Wang D, Dzau V, Prate R. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation. 1994;90:449-455.
25. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
26. DeFeyter PJ, Suryapranata H, Serruys PW, Beatt K, Van Domburg R, Van Den Brand M, Tijssen JJ, Azar AJ, Hugenholtz PG. Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J Am Coll Cardiol. 1988;12:324-333.
27. Shah PK, Pasternak R. The role of lipids in restenosis following angioplasty. Curr Opin Lipidemiol. 1993;4:310-313.
28. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Fibrinogen after coronary angiuplasty as a risk factor for restenosis. Circulation. 1995;92:31-38.
29. Holmes DR Jr, Vietstra RE, Smith HC, Vetrovec GW, Kent KM, Loweley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Muck MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984;53:77C-81C.
30. Carrozza JP, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary scenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
31. Aronson D, Bloomgarden Z, Rayfileld E. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27:528-535.
32. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin-II receptors and angiotensin-II receptor antagonists. Pharmacol Rev. 1993;45:205-225.
33. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphisin in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
34. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993;342:1073-1075.
35. Lindpaintner K. Lee M, Larson MG, Srinivas Rao V, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PEF, Vasan RS, Myers RH, Levy D. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med. 1996;334:1023-1028.
36. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996;94:708-712.
37. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation. 1992;86:100-110.
38. Faxon DP, the Multicenter American Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction, and Restenosis (MARCATOR) Study Group. Effect of the high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol. 1995;25:362-369.
39. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphisin: what to do about all the confusion? Circulation. 1996;94:236-239.
40. Lafont A, Guerot C, Lemarchand P. Which gene for which restenosis? Lancet. 1995;346:1442-1443.